Simon Corman has over 20 years of experience as a cutting-edge leader in clinical research. His strengths revolve around corporate and business development- with an ability to create strategic partnerships with various CROs and Sponsors and form public-private partnerships that support…
Innovating Our Services Alongside Our Ambulance of Research!
FOMAT is committed to providing high-quality services. We also aim to bring diversity and innovative healthcare to underrepresented populations in our community. That is why we present to you our company’s new ambulance! With our ambulance, we plan on engaging in…
Why Volunteer in Clinical Trials?
Why volunteer in clinical trials? Here’s a summary of the reasons why clinical trials are important Clinical trials are research studies that use human participants to help evaluate new medical treatments, drugs, or devices. They are an essential tool that helps…
FOMAT Medical Research Awarded as “Innovative Company of the Year”
The Oxnard Chamber of Commerce has awarded FOMAT as the Innovative Company of the Year. Oxnard, California, October 5th, 2020 FOMAT Medical Research, is a company focused on the pharmaceutical industry, based in Oxnard, California, and has over 10…
FDA Action Alert: Viela, Merck, Epizyme, Evoke and Regeneron
The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period. Viela Bio’s Inebilizumab for NMOSD Gaithersburg, Maryland-based Viela Bio has a target action date of June 11 for its Biologics License…
FOMAT Medical Research announces a partnership with Febo
Febo is a digital upstart, with its sights set on empowering patients by transforming the way they educate themselves. Febo is an online platform where you can get personalized information about your medical interests and stay updated on the newest developments,…
FOMAT Makes Waves at SCRS 19
Last weekend several prominent members of the clinical research industry gathered at the 2019 Global Site Solutions Summit hosted at the Diplomat Beach Resort in Hollywood Florida. This marks the 14th year in a row that the event has been held, and…
A ‘One-Two Punch’ to Wipe Out Cancerous Ovarian Cells
Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the superior therapeutic effectiveness of the “one-two punch” on cells…
What Do Cros and Sponsor Consider When Selecting a Site?
Within the pharmaceutical industry, 45% of clinical trials are completed late, or 70%-80% of studies are delayed or do not meet their timelines. Due to these reasons, one of the main goals for a CRO is to create a mitigating strategy…
hyperCORE wins ACRP- All-Star Challenge
hyperCORE International took first place in the inaugural ACRP All-Star Challenge for Sites during the ACRP 2019 annual conference in Nashville. Vanderbilt University Medical Center took second place, and Sarah Cannon Research Institute placed third.“Congratulations to the team from hyperCORE International…